Recombinant Peptide deformylase (def)

What is peptide deformylase and where is it found in cells?

Peptide deformylase (PDF) is a metalloprotease found in bacteria, plants, and humans that removes the N-formyl group from the initiating N-formyl-methionine of nascent peptides. In human cells, the human homolog of peptide deformylase (HsPDF) resides specifically in the mitochondria, where it co-localizes with its putative formylated substrates. This enzyme belongs to a conserved family of metalloproteases that are essential for proper protein maturation .

In bacteria, PDF is found in the cytoplasm, while in eukaryotes, N-terminal formylation is limited to the 13 mitochondrial DNA (mtDNA)-encoded proteins. The formylation process is particularly important for translation initiation in mitochondria, as formyl-Met-tRNA, but not Met-tRNA, is recognized by initiation factor 2 as the initiator tRNA .

What is the functional significance of deformylation in cellular processes?

Deformylation serves as a critical post-translational modification that impacts multiple cellular processes:

• Mitochondrial Function: HsPDF-mediated processing of mtDNA-encoded proteins is necessary for proper function of the respiratory chain complexes. Inhibition of HsPDF reduces mtDNA-encoded protein accumulation, impairs new respiratory complex assembly, and decreases energy production by mitochondria .

• Protein Maturation: Deformylation is required for subsequent N-terminal methionine cleavage by methionine aminopeptidase (MAP), an event that occurs for approximately half of all proteins. This sequential processing is essential for proper protein maturation and function .

• Cellular Viability: In bacteria, deformylation is essential for viability. In human cells, disruption of HsPDF function leads to a metabolic shift toward aerobic glycolysis, suggesting its importance in cellular energy homeostasis .

• Nascent Protein Biogenesis: The timing of deformylation is critically important as it occurs co-translationally, shortly after the nascent chain emerges from the ribosomal exit tunnel. This timing allows for coordinated processing of the N-terminus .

How can I measure PDF activity in vitro and in cellular systems?

PDF activity can be assessed through multiple complementary approaches:

In Vitro Enzymatic Assays:

• Chromogenic Substrate Method: Using formylated peptide substrates such as formyl-methionyl-leucyl-p-nitroaniline (fMLpNA), deformylation can be monitored spectrophotometrically. This method has revealed deformylation rates of 20–40 s⁻¹ and up to 1000 s⁻¹ depending on amino acid composition .

• Thin-Layer Chromatography (TLC): For ribosome-nascent chain complexes (RNCs), separation of [³⁵S]fMet and [³⁵S]Met by TLC following deformylation allows for visualization and quantification by phosphoimaging .

Cellular Systems Approaches:

• Pulse-Chase Experiments: Incorporation of [³⁵S]Met-Cys into mitochondrial translation products, followed by pulse-chase experiments in the presence of PDF inhibitors or vehicle controls. This approach can track the synthesis and processing of mtDNA-encoded proteins .

• Western Blotting: Treatment of cells with specific PDF inhibitors (e.g., actinonin, actinonamide) followed by Western blotting for mtDNA-encoded proteins can assess the impact of PDF inhibition on protein accumulation .

What are the optimal conditions for studying PDF kinetics on ribosome-bound nascent chains?

When studying PDF kinetics on ribosome-bound nascent chains, consider these optimal conditions:

• Nascent Chain Length: Maximal PDF activity is achieved when the chain length is approximately 70 amino acids, although some activity can be detected with chains as short as 50 amino acids. This length ensures proper emergence from the ribosomal exit tunnel .

• Temperature and pH: Standard enzymatic reaction conditions (typically 37°C, physiological pH) should be maintained for optimal activity.

• Substrate Selection: Different nascent peptides (e.g., proOmpA, RNaseH, TolB, DnaK) show varying deformylation rates, with kcat values ranging from 0.04 to 0.26 s⁻¹, while maintaining similar KM values. Selection of an appropriate substrate is important for kinetic studies .

• Enzyme Concentration: For multiple-turnover conditions, PDF concentration should be lower than RNC concentration. For single-turnover conditions, excess PDF should be used .

Table 1: Kinetic parameters for PDF-catalyzed deformylation of different ribosome-nascent chain complexes (RNCs) compared to the model substrate fMLpNA .

What is the rate-limiting step in the PDF deformylation mechanism?

The rate-limiting step in PDF catalysis differs between soluble peptide substrates and ribosome-bound nascent chains:

How does PDF interact with other co-translational processing factors?

PDF's interactions with other co-translational processing factors create a complex regulatory network:

• Competitive Binding: PDF interacts via its C-terminal helix with ribosomal protein L22 near the tunnel exit. Its binding site overlaps with that of methionine aminopeptidase (MAP), resulting in competitive binding between these two enzymes .

• Non-Competitive Interactions: Other factors, including the chaperone trigger factor (TF) or signal recognition particle (SRP), can bind to the ribosome simultaneously with PDF in a non-competitive manner, though simultaneous binding of PDF, TF, and MAP may impair TF function .

• Coordinated Processing: The actions of different protein biogenesis factors are coordinated by the ribosome, which provides a binding platform for PDF, MAP, and SRP in the vicinity of the tunnel exit where the N-terminus of a nascent protein emerges .

• Sequential Processing: Deformylation by PDF must precede N-terminal methionine cleavage by MAP, creating a defined sequence of processing events during protein synthesis .

What is the role of HsPDF in mitochondrial function and disease?

HsPDF plays critical roles in mitochondrial function that have implications for various diseases:

• Respiratory Complex Assembly: HsPDF is necessary for the accumulation of mitochondrial DNA-encoded proteins and assembly of new respiratory complexes. These mtDNA-encoded proteins are all subunits of four of the five oxidative phosphorylation respiratory chain enzyme complexes (I, III, IV, and V) .

• Energy Production: Inhibition of HsPDF reduces respiratory function and cellular ATP levels, causing dependence on aerobic glycolysis for cell survival. This metabolic shift resembles the Warburg effect observed in cancer cells .

• Neurodegenerative Diseases: Mutations in human mtDNA that affect protein-coding regions or nuclear DNA mutations that affect expression of respiratory complex subunits cause diseases, including Parkinson's disease, where decreased respiratory function and compromised cell viability have been demonstrated .

• Cancer: Human mitochondrial PDF is upregulated in cancer cells, making it a potential drug target. PDF inhibitors such as actinonin are being explored for potential use in anticancer treatment .

How do PDF inhibitors affect cellular metabolism and viability?

PDF inhibitors elicit specific cellular responses that provide insights into both PDF function and potential therapeutic applications:

• Mitochondrial Membrane Depolarization: Pharmacologic inhibition with PDF inhibitors like actinonin results in mitochondrial membrane depolarization, a key indicator of mitochondrial dysfunction .

• ATP Depletion: Treatment with PDF inhibitors leads to reduced cellular ATP levels, particularly affecting ATP produced through oxidative phosphorylation. In the absence of glucose, where cells cannot rely on glycolysis for ATP production, PDF inhibition causes more pronounced ATP depletion .

• Cell Death or Proliferation Arrest: PDF inhibitors promote cell death or proliferation arrest in a wide variety of cancer cell lines, suggesting their potential as anticancer agents .

• Glycolysis Dependence: Cells treated with PDF inhibitors become increasingly dependent on aerobic glycolysis for survival, indicating a metabolic reprogramming response to compromised mitochondrial function .

How can discrepancies between in vitro and cellular PDF activity be resolved?

Researchers often encounter differences between PDF activity measured in vitro versus in cellular contexts. These discrepancies can be addressed through:

• Substrate Considerations: In vitro deformylation assays using model substrates like fMLpNA show rates of 20–40 s⁻¹, while RNC deformylation proceeds at only 0.04-0.26 s⁻¹. This difference highlights the importance of using physiologically relevant substrates in activity assessments .

• Ribosomal Context: PDF activity on the ribosome is influenced by interactions with ribosomal proteins and potentially other ribosome-associated factors. In vitro assays should incorporate ribosomes or RNCs when possible to better reflect cellular conditions .

• Post-Cleavage Events: The rate-limiting conformational rearrangement step that occurs after deformylation is only observable in the ribosomal context. Assays that measure only chemical cleavage may overestimate the physiological rate of complete deformylation processing .

• Competitive Binding: In cells, PDF competes with other factors like MAP for binding to the ribosome, which may influence its effective activity. In vitro systems should account for these competitive interactions when possible .

What controls should be included when assessing the effects of PDF inhibitors in experimental settings?

When using PDF inhibitors in experimental studies, appropriate controls are essential for accurate interpretation:

• Vehicle Controls: Include DMSO (0.1%) or appropriate vehicle controls to account for solvent effects .

• Structurally Different Inhibitors: Employ a series of structurally different HsPDF inhibitors to confirm that observed effects are due to PDF inhibition rather than off-target effects. For example, both actinonin and actinonamide should yield similar results if the effect is PDF-specific .

• Control Peptidase Inhibitors: Include inhibitors of other peptidases, such as bestatin (an aminopeptidase inhibitor), to differentiate between PDF-specific effects and general peptidase inhibition .

• Translation Inhibitors: Controls with chloramphenicol or other mitochondrial translation inhibitors can help distinguish between effects due to inhibition of deformylation versus general inhibition of mitochondrial translation .

• Metabolic Controls: When assessing metabolic effects, perform experiments in both glucose-containing and glucose-free media to evaluate the dependence on glycolysis .